In this time of dire need, Sepragen team is doing its part to solve the problem of COVID-19. We are providing equipment on an expedited basis to a company developing a vaccine for COVID- 19.
Processes for Health-Enhancing Human Nutritionals

Processes for Health-Enhancing Human Nutritionals

In the creation of bio-pharmaceutical drugs, cells are genetically modified to produce some compound shown by research to have a desired effect in a treatment program. First there’s the genetic engineering to discover a compound and then how to modify a cell to produce the compound. Essentially the cell becomes a chemical factory secreting a certain compound. The cells are then grown in a manner similar to how beer is produced in vats called “bioreactors”.

These cells typically produce very big macro molecules (ranging in molecular weight from 50,000 to well over 100,000), most are proteins, some are peptides. This differs from traditional pharmaceuticals which are generally made from much smaller molecules.
news
You may also like
Browse All
January 2023
Sepragen ships
In the creation of bio-pharmaceutical drugs, cells are genetically modified to produce some compound shown by research to have a desired effect in a treatment program.
Learn more
December 2022
Sepragen completes installation
Sepragen’s products or tools are used to manufacture over 24 FDA approved drugs including Kogenate®, Alphanate®, Neupogen®, and GammaGrand®* along with a multitude...
Learn more
July 2022
Sepragen presents at the Recovery Conference in Rome
Sepragen has pioneered the three patented processes for the isolation of high value nutritionals on a commercial scale. The Sepralac® Process enables the isolation of Lactoferrin...
Learn more